ADARx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
ADARx Pharmaceuticals raised $446.3 million in an upsized US initial public offering, pricing 26.3 million shares at $17 each, the top end of its marketed range. The San Diego-based biotech had initially planned to...
Electra Therapeutics Targets Up to $978 Million Valuation in U.S. IPO
Drug developer Electra Therapeutics is targeting a valuation of up to $977.6 million in its U.S. initial public offering, according to a filing on Monday, adding to a broader recovery in biotech listings this...
Bamboo Insurance Targets Up to $3.24 Billion Valuation in U.S. IPO
CVC-backed Bamboo Insurance Services is targeting a valuation of up to $3.24 billion in its U.S. initial public offering, according to a filing on Monday. The Midvale, Utah-based residential property insurer plans to offer...
Kioxia Considers $10 Billion U.S. ADR Listing
Japanese chipmaker Kioxia Holdings is considering raising at least $10 billion through a listing of American depositary receipts (ADRs) in the United States, Bloomberg News reported on Monday, citing people familiar with the matter....
AI Warnings Trigger Nasdaq Selloff as Tech Stocks Slide
U.S. stock futures fell sharply on Monday, led by the Nasdaq 100, as major technology and semiconductor stocks came under pressure following calls from leading AI executives to slow the development of increasingly powerful...
Amazon Plans First-Ever Sterling Bond Sale as AI Funding Needs Grow
Amazon has hired banks for its first-ever sterling bond sale, according to a memo seen by Reuters, as major technology companies increasingly tap global debt markets to fund the surge in spending driven by...
Asian Stocks Slide as Yen Surges and Iran Tensions Lift Oil Prices
Asian stocks fell on Tuesday as a sharp surge in the yen, mixed economic data and rising geopolitical tensions weighed on investor sentiment. The yen climbed as much as 1% to 152.89 per dollar,...
Yorkville America Eyes Acquisition as It Expands Beyond Truth Social ETFs
Yorkville America, the asset manager behind President Donald Trump’s Truth Social exchange-traded funds, is nearing an acquisition that would significantly broaden its investment-product lineup, CEO Steve Neamtz told Reuters. The transaction, involving an institutional...












